JP Patent

JP6829224B2 — てんかんまたはてんかん重積状態の処置方法

Assigned to Sage Therapeutics LLC · Expires 2021-02-10 · 5y expired

What this patent protects

Patent listed against Zulresso.

Drugs covered by this patent

Patent Metadata

Patent number
JP6829224B2
Jurisdiction
JP
Classification
—
Expires
2021-02-10
Drug substance claim
No
Drug product claim
No
Assignee
Sage Therapeutics LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.